ESTABLISHING CUT-OFF OF INFLIXIMAB LEVELS AND ANTI-INFLIXIMAB ANTIBODIES BY COMMERCIAL ELISA IN PATIENTS WITH RHEUMATOID ARTHRITIS

被引：1
|
作者：
Hernandez, Diana [1 ]
Valor, Lara [1 ]
de la Torre, Inmaculada [1 ]
Martinez, Lina [1 ]
Carlos Nieto, Juan [1 ]
del Rio, Tamara [1 ]
Naredo, Esperanza [1 ]
Gonzalez, Carlos [1 ]
Lopez-Longo, Javier [1 ]
Montoro, Maria [1 ]
Monteagudo, Indalecio [1 ]
Carreno, Luis [1 ]
机构：
[1] Hosp Gen Univ Gregorio Maranon, Dept Rheumatol, Madrid, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2013-205124.25
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A1.26
引用
收藏
页码：A11 / A11
页数：1
相关论文
共 50 条
  • [1] ESTABLISHING CUT-OFF OF INFLIXIMAB AND ANTI-INFLIXIMAB ANTIBODY LEVELS USING A COMMERCIAL ELISA IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Hernandez, D.
    De la Torre, I.
    Martinez, L.
    Nieto, J.
    Llinares, F.
    Rosas, J.
    Gonzalez, C.
    Monteagudo, I.
    Lopez-Longo, J.
    Montoro, M.
    Carreno, L.
    Valor, L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 237 - 237
  • [2] Cut-off levels and diagnostic accuracy of infliximab trough levels and anti-infliximab antibodies in Crohn's disease
    Steenholdt, Casper
    Bendtzen, Klaus
    Brynskov, Jorn
    Thomsen, Ole Ostergaard
    Ainsworth, Mark Andrew
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2011, 46 (03) : 310 - 318
  • [3] Identification of a cut-off for persistent anti-infliximab antibodies as a predictor of response to infliximab monotherapy
    Del Nero, L.
    Bodini, G.
    Giannini, E.
    Anjali, J.
    Savarino, V.
    Savarino, E.
    [J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 : S270 - S271
  • [4] IDENTIFICATION OF A CUT-OFF FOR PERSISTENT ANTI-INFLIXIMAB ANTIBODIES AS A PREDICTOR OF RESPONSE TO INFLIXIMAB MONOTHERAPY
    Del Nero, L.
    Bodini, G.
    Giannini, E. G.
    Savarino, V
    De Maria, C.
    Baldissarro, I
    Savarino, E.
    [J]. DIGESTIVE AND LIVER DISEASE, 2016, 48 : E77 - E77
  • [5] Clinical Response in Rheumatoid Arthritis Patients with Anti-Infliximab Antibodies
    Opris, Daniela
    Mazilu, Diana
    Ionescu, Ruxandra
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (04) : S40 - S41
  • [6] The Monitoring of Infliximab Levels at Early Stages Can Predict the Development of Anti-Infliximab Antibodies in a Cohort of Rheumatoid Arthritis Patients Treated with Infliximab
    Plasencia-Rodriguez, Chamaida
    Pascual-Salcedo, Dora
    Gema Bonilla, Maria
    Villalba, Alejandro
    Peiteado, Diana
    Nuno, Laura
    Aguado, Pilar
    Jurado, Teresa
    Martin-Mola, Emilio
    Balsa, Alejandro
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1098 - S1098
  • [7] Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patients
    Finckh, Axel
    Dudler, Jean
    Wermelinger, Felix
    Ciurea, Adrian
    Kyburz, Diego
    Gabay, Cem
    Bas, Sylvette
    [J]. JOINT BONE SPINE, 2010, 77 (04) : 313 - 318
  • [8] Commentary: detection of infliximab levels and anti-infliximab antibodies
    Seow, C. H.
    Panaccione, R.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (01) : 153 - 154
  • [9] INFLIXIMAB LEVELS AND ANTI-INFLIXIMAB ANTIBODIES COMPARISON BETWEEN TWO COMERCIAL ELISA VERSIONS IN PATIENTS WITH ANKYLOSING SPONDYLITIS
    Hernandez Florez, D.
    Valor, L.
    Nieto, J. C.
    Martinez, L.
    de la Torre, I.
    del Rio, T.
    Gonzalez, C.
    Lopez-Longo, J.
    Monteagudo, I.
    Naredo, E.
    Montoro, M.
    Carreno Perez, L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 715 - 716
  • [10] Anti-infliximab antibodies in patients with rheumatoid arthritis who require higher doses of infliximab to achieve or maintain a clinical response
    Haraoui, B
    Cameron, L
    Ouellet, M
    White, B
    [J]. JOURNAL OF RHEUMATOLOGY, 2006, 33 (01) : 31 - 36
12345